An annual report on consumer expenditures from the US Bureau of Labor Statistics shows that a trend begun more than a decade ago is continuing: an increase in average annual consumer expenditures for healthcare.
An annual report on consumer expenditures from the US Bureau of Labor Statistics shows that a trend begun more than a decade ago is continuing: an increase in average annual consumer expenditures for healthcare.
A rise in overall healthcare spending, from $2,976 in 2008 to $3,157 in 2010, was driven by an 10.8% increase in consumer health insurance spending over the period, although the increase from 2009 to 2010 was a modest 2.6%. Yet spending for medical services, which includes physician visits, fell 1.9% between 2009 and 2010, the report shows, suggesting that consumers are compensating for higher insurance costs by cutting back on care.
Between 2001 and 2011, workers have seen an increase of 131% in their contributions to employer-sponsored health insurance premiums and employers have had a 113% increase in premium costs, which they increasingly are shifting to employees. For example, the percentage of covered workers enrolled in a high-deductible health plan with a savings option rose from 8% in 2009 to 17% in 2011, according to a Kaiser Family Foundation survey.
Bureau of Labor Statistics, US Department of Labor. Consumer Expenditures-2010. http://www.bls.gov/news.release/cesan.nr0.htm. Accessed November 16, 2011.
Kaiser Family Foundation and Health Research & Educational Trust. Employer Health Benefits: 2011 Summary of Findings. http:ehbs.kff.org/pdf/8226.pdf. Accessed November 16, 2011.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More